These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19152171)

  • 1. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
    Zenhäusern R; Von Rohr A; Rufibach K; Solenthaler M; Meyer-Monard S; Gratwohl A; Hess U; Bargetzi MJ; Kovacsovic T; Leoncini L; Tobler A;
    Leuk Lymphoma; 2009 Jan; 50(1):133-6. PubMed ID: 19152171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
    Nielsen OJ; Hippe E; Priø TK; Juliusson G
    Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
    Zenhäusern R; Simcock M; Gratwohl A; Hess U; Bargetzi M; Tobler A;
    Haematologica; 2008 Sep; 93(9):1426-8. PubMed ID: 18603561
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of 2-chlorodeoxyadenosine in nodal and extra haematopoietic localizations in hairy cell leukaemia.
    Rieux C; Bastion Y; Bazin M; Dumontet C; Coiffier B; Felman P; Bryon PA
    Eur J Haematol; 1995 Aug; 55(2):133-5. PubMed ID: 7628589
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
    von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
    Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
    Juliusson G; Heldal D; Hippe E; Hedenus M; Malm C; Wallman K; Stolt CM; Evensen SA; Albertioni F; Tjønnfjord G
    J Clin Oncol; 1995 Apr; 13(4):989-95. PubMed ID: 7707128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K; Zák P
    Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of one hairy cell leukemia case with single course of cladribine].
    Zhang LJ; Qiu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    Carbone A; Reato G; Di Celle PF; Lauria F; Foa R
    Leukemia; 1994 Nov; 8(11):2019-20. PubMed ID: 7967746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hairy cell leukemia therapy by cladribine].
    Ogura M
    Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative methods of cladribine administration.
    Lauria F; Cencini E; Forconi F
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():34-7. PubMed ID: 21504286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cladribine (2-chlorodeoxyadenosine).
    Beutler E
    Lancet; 1992 Oct; 340(8825):952-6. PubMed ID: 1357355
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia.
    Saven A; Piro LD
    Cancer Invest; 1993; 11(5):559-64. PubMed ID: 8104670
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Chlorodeoxyadenosine treatment in hairy cell leukemia.
    Anand A
    Ann Intern Med; 1994 Jan; 120(2):169. PubMed ID: 7903027
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose cladribine for symptomatic hairy cell leukaemia.
    Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
    Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.